# US 2017/0247735 A1 · Methods and Materials for Biosynthesis of Mogroside Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0247735 A1
- Document ID: US20170247735A1
- Status: Published application
- Kind: A1
- Application number: 15/511,565
- Filed: 2015-09-30
- Published: 2017-08-31
- Earliest claimed: 2014-10-02
- Assignees: Evolva SA
- Applicants: Evolva SA
- Inventors: Jens Houghton-Larsen; Katarzyna Krzystanek; Angelika Semmler; Iver Klavs Riishede Hansen; Soren Damkiaer; Gary Liu; Yaoquan Liu; Jorgen Hansen; Sathish Kumar; Muthuswamy Panchapagesa Murali; Nina Nicoline Rasmussen
- Web page: https://patentgrep.com/patent/US20170247735A1

## CPC

- C12P 33/00: Preparation of steroids
- A23L 27/36: {Terpene glycosides}
- C07H 1/06: Separation; Purification
- C12N 9/0014: {acting on the CH-NH2 group of donors (1.4)}
- C12N 9/0042: {NADPH-cytochrome P450 reductase (1.6.2.4)}
- C12N 9/0071: {acting on paired donors with incorporation of molecular oxygen (1.14)}
- C12N 9/0073: {with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13}
- C12N 9/1051: {Hexosyltransferases (2.4.1)}
- C12N 9/14: Hydrolases (3)
- C12N 9/90: Isomerases (5.)
- C12N 15/00: Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms, per se C12N1/00, C12N5/00, C12N7/00; new plants per se A01H; plant reproduction by tissue culture techniques A01H4/00; new animals per se A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00)
- C12P 19/18: produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
- C12P 19/56: having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Methods for recombinant and enzymatic production of mogroside compounds and compositions containing mogroside compounds are provided by this invention.

## Claims

### Claim 1

A recombinant host comprising one or more of:
(a) a gene encoding a squalene epoxidase polypeptide;
(b) a gene encoding a cucurbitadienol synthase polypeptide;
(c) a gene encoding a cytochrome P450 polypeptide;
(d) a gene encoding a cytochrome P450 reductase polypeptide;
(e) a gene encoding an epoxide hydrolase polypeptide;
(f) a gene encoding a UGT1576 polypeptide having 60% or greater identity to an amino acid sequence set forth in SEQ ID NO:48;
(g) a gene encoding a UGT430 polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:62;
(h) a gene encoding a UGT1697 polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:68;
(i) a gene encoding a UGT11789 polypeptide having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:72;
(j) a gene encoding a UGT98 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:53;
(k) a gene encoding a UGTSK98 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:50;
wherein at least one of the genes is a recombinant gene;
wherein the host is capable of producing a mogrol precursor, a mogroside precursor, and/or a mogroside compound.

### Claim 2 (depends on 1)

The recombinant host of claim 1, wherein:
(a) the squalene epoxidase polypeptide comprises a polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:54;
(b) the cucurbitadienol synthase polypeptide comprises a polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:43;
(c) the cytochrome P450 polypeptide comprises a CYP5491 polypeptide having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:44 and/or a CYP1798 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:74;
(d) the cytochrome P450 reductase polypeptide comprises a CPR4497 polypeptide having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:46; and/or
(e) the epoxide hydrolase polypeptide comprises an epoxide hydrolase 1 polypeptide having 75% or greater identity to an amino acid sequence set forth in SEQ ID NO:38 or an epoxide hydrolase 2 polypeptide having 65% or greater identity to an amino acid sequence set forth in SEQ ID NO:40.

### Claim 3

A recombinant host comprising one or more of:
(a) one or more genes encoding one or more enzymes capable of catalyzing conversion of dioxidosqualene to produce 24,25 epoxy cucurbitadienol;
(b) one or more genes encoding one or more enzymes capable of catalyzing conversion of oxidosqualene to produce cucurbitadienol;
(c) one or more genes encoding one or more enzymes capable of catalyzing hydroxylation of 24,25 epoxy cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol;
(d) one or more genes encoding one or more enzymes capable of catalyzing hydroxylation of cucurbitadienol to produce 11-hydroxy-cucurbitadienol;
(e) one or more genes encoding one or more enzymes capable of catalyzing epoxidation of cucurbitadienol to produce 24,25 epoxy cucurbitadienol; or
(f) one or more genes encoding one or more enzymes capable of catalyzing epoxidation of 11-hydroxy-cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol;
(g) one or more genes encoding one or more enzymes capable of catalyzing conversion of 11-hydroxy-24,25 epoxy cucurbitadienol to produce mogrol; or
(h) one or more genes encoding one or more enzymes capable of catalyzing glycosylation of a mogroside precursor to produce a mogroside compound;
wherein at least one of the genes is a recombinant gene.

### Claim 4 (depends on 3)

The recombinant host of claim 3, further comprising a gene encoding squalene epoxidase polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:54.

### Claim 5 (depends on 1, 2, 3, 4)

The recombinant host of any one of claims 1-4, wherein the recombinant host has been modified to reduce expression of a lanosterol synthase (ERG7) polypeptide.

### Claim 6 (depends on 5)

The recombinant host of claim 5, wherein the ERG7 polypeptide comprises a polypeptide having an amino acid sequence set forth in SEQ ID NO:55.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

A method of producing a mogroside precursor and/or a mogroside compound, comprising:
(a) growing the recombinant host of any one of claims 1-6 in a culture medium, under conditions in which the genes disclosed in any one of claims 1-6 are expressed;
wherein the mogroside precursor and/or the mogroside compound is synthesized by the recombinant host; and
(b) optionally isolating the mogroside precursor and/or the mogroside compound.

### Claim 8 (depends on 7)

The method of claim 7, wherein the mogroside precursor is mogrol synthesized by epoxidation of 11-hydroxy-cucurbitadienol to synthesize 11-hydroxy-24,25 epoxy cucurbitadienol and hydrolysis of 11-hydroxy-24,25 epoxy cucurbitadienol to synthesize mogrol.

### Claim 9 (depends on 8)

The method of claim 8, wherein epoxidation of 11-hydroxy-cucurbitadienol to synthesize 11-hydroxy-24,25 epoxy cucurbitadienol is catalyzed by the CYP1798 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:74.

### Claim 10

A method of producing a mogrol precursor in vitro, comprising:
(a) contacting dioxidosqualene with one or more enzymes capable of catalyzing conversion of dioxidosqualene to produce 24,25 epoxy cucurbitadienol; or
(b) contacting oxidosqualene with one or more enzymes capable of catalyzing conversion of oxidosqualene to produce cucurbitadienol; or
(c) contacting 24,25 epoxy cucurbitadienol with one or more enzymes capable of catalyzing hydroxylation of 24,25 epoxy cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol; or
(d) contacting cucurbitadienol with one or more enzymes capable of catalyzing hydroxylation of cucurbitadienol to produce 11-hydroxy-cucurbitadienol; or
(e) contacting cucurbitadienol with one or more enzymes capable of catalyzing epoxidation of cucurbitadienol to produce 24,25 epoxy cucurbitadienol; or
(f) contacting 11-hydroxy-cucurbitadienol with one or more enzymes capable of catalyzing epoxidation of 11-hydroxy-cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol.

### Claim 11

A method of producing a mogrol in vitro, comprising contacting 11-hydroxy-24,25 epoxy cucurbitadienol with one or more enzymes capable of catalyzing conversion of 11-hydroxy-24,25 epoxy cucurbitadienol to produce mogrol.

### Claim 12

A method of producing a mogroside compound in vitro, comprising contacting a mogroside precursor with one or more enzymes capable of catalyzing glycosylation of the mogroside precursor to produce a mogroside compound.

### Claim 13 (depends on 10, 11, 12)

The method of any one of claims 10-12, further comprising isolating the mogrol precursor, mogrol or the mogroside compound.

### Claim 14 (depends on 3, 10, 11, 12, 13)

The recombinant host of claim 3 or the method of any one of claims 10-13, wherein:
(a) the one or more enzymes capable of catalyzing conversion of dioxidosqualene to produce 24,25 epoxy cucurbitadienol comprise a cucurbitadienol synthase having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:43;
(b) the one or more enzymes capable of catalyzing conversion of oxidosqualene to produce cucurbitadienol comprise a cucurbitadienol synthase having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:43;
(c) the one or more enzymes capable of catalyzing conversion of 24,25 epoxy cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol comprise CYP5491 having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:44;
(d) the one or more enzymes capable of catalyzing conversion of cucurbitadienol to produce 11-hydroxy-cucurbitadienol comprise CYP5491 having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:44;
(e) the one or more enzymes capable of catalyzing epoxidation of cucurbitadienol to produce 24,25 epoxy cucurbitadienol comprise CYP1798 having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:74;
(f) the one or more enzymes capable of catalyzing epoxidation of 11-hydroxy-cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol comprise CYP1798 having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:74;
(g) the one or more enzymes capable of catalyzing conversion of 11-hydroxy-24,25 epoxy cucurbitadienol to produce mogrol comprise a polypeptide comprising epoxide hydrolase 1 having 75% or greater identity to an amino acid sequence set forth in SEQ ID NO:38 or epoxide hydrolase 2 having 65% or greater identity to an amino acid sequence set forth in SEQ ID NO:40; and/or
(h) the one or more enzymes capable of catalyzing conversion of the mogroside precursor to a mogroside compound comprise UGT1576 having 60% or greater identity to an amino acid sequence set forth in SEQ ID NO:48; UGT98 having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:53; UGTSK98 having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:50; UGT430 having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:62; UGT1697 having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:68; or UGT11789 having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:72.

### Claim 15

A method of producing a mogroside compound, comprising contacting a recombinant host expressing one or more of:
(a) a UGT1576 polypeptide having 60% or greater identity to an amino acid sequence set forth in SEQ ID NO:48;
(b) a UGT430 polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:62;
(c) a UGT1697 polypeptide having 45% or greater identity to an amino acid sequence set forth in SEQ ID NO:68;
(d) a UGT11789 polypeptide having 50% or greater identity to an amino acid sequence set forth in SEQ ID NO:72;
(e) a UGT98 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:53; or
(f) a UGTSK98 polypeptide having 70% or greater identity to an amino acid sequence set forth in SEQ ID NO:50 with a mogroside precursor.

### Claim 16 (depends on 15)

The method of claim 15, wherein the mogroside precursor is plant-derived or synthetic.

### Claim 17 (depends on 15)

The method of claim 15, further comprising isolating the mogroside compound.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 12, 13, 14)

The recombinant host of any one of claims 1-6 or the method of claim 7 or 12-14, wherein the mogroside compound is:
(a) mogrol glycosylated at C3 position; or
(b) mogrol glycosylated at C24 position; or
(c) mogrol glycosylated at C3 position and C24 position.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17)

The recombinant host of any one of claims 1-6 or the method of claim 7 or 12-17, wherein the mogroside compound is one or more of mogroside I A1, mogroside I E1, mogroside II A, mogroside II A1, mogroside II A2, mogroside II E, mogroside III A1, mogroside III A2, mogroside III, mogroside III E, mogroside IV, mogroside IV A, mogroside V or siamenoside.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 10, 13)

The recombinant host of any one of claims 1-6 or the method of claim 10 or 13, wherein the mogrol precursor is one or more of squalene, dioxidosqualene, oxidosqualene, 24,25 epoxy cucurbitadienol, cucurbitadienol, 11-hydroxy-cucurbitadienol, 11-hydroxy 24, 25 epoxy cucurbitadienol or 11-oxo-mogrol.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 12, 14, 15, 16, 17)

The recombinant host of any one of claims 1-6 or the method of claim 7-9, 12 or 14-17, wherein the mogroside precursor is one or more of mogrol, glycosylated mogrol, di-glycosylated mogrol or tri-glycosylated mogrol.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The method of any one of claim 7, 8-13 or 15-17 or the recombinant host of any one of claim 1-6, 14 or 18-21, wherein the recombinant host comprises a microorganism that is a yeast cell, a plant cell, a mammalian cell, an insect cell, a fungal cell, or a bacterial cell.

### Claim 23

The bacterial cell according to 22, wherein the bacterial cell comprises Escherichia bacteria cells, Lactobacillus bacteria cells, Lactococcus bacteria cells, Cornebacterium bacteria cells, Acetobacter bacteria cells, Acinetobacter bacteria cells, or Pseudomonas bacterial cells.

### Claim 24 (depends on 22)

The yeast cell according to claim 22, wherein the yeast cell is a cell from Saccharomyces cerevisiae, Schizosaccharomyces pombe, Yarrowia lipolytica, Candida glabrata, Ashbya gossypii, Cyberlindnera jadinli, Pichia pastoris, Kluyveromyces lactis, Hansenula polymorphs, Candida boidinii, Arxula adeninivorans, Xanthophyllomyces dendrorhous, or Candida albicans species.

### Claim 25 (depends on 24)

The yeast cell of claim 24, wherein the yeast cell is a Saccharomycete.

### Claim 26 (depends on 25)

The yeast cell of claim 25, wherein the yeast cell is a cell from the Saccharomyces cerevisiae species.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 14)

The recombinant host of any one of claim 1-6 or 14, wherein one or more of the genes further comprise a nucleotide sequence coding a fusion tag.

### Claim 28 (depends on 27)

The recombinant host of claim 27, wherein the fusion tag is a protein or polypeptide.

### Claim 29 (depends on 28)

The recombinant host of claim 28, wherein the fusion tag is green fluorescent protein (GFP), human influenza hemagglutinin (HA), glutathione S transferase (GST), a polyhistidine-tag (HIS tag), and a FLAG-tag, a chloroplast transit peptide, a mitochondrial transit peptide, an amyloplast peptide, a signal peptide, or a secretion tag.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 12)

The recombinant host of any one of claim 1-6, 12, or 25-27, wherein one or more of the genes are expressed as fusion proteins.

### Claim 31 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

A mogroside composition produced by the recombinant host of any one of claim 1-6, 16, or 27-29 or the method of any one of claim 7, 8-13 or 13-17, wherein the composition comprises one or more of mogroside I A1, mogroside I E1, mogroside II A, mogroside II E, mogroside III A1, mogroside III A2, mogroside III, mogroside III E, mogroside IV, mogroside V, and siamenoside.

### Claim 32 (depends on 31)

A food or drink product comprising the composition of claim 31.
